H. Mao

发表

Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients

Xuan Wei, Peishu Liu, Xueyao Huang, 2021, Cancer management and research.

Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Xuan Wei, Weiping Lu, Peishu Liu, 2020, Frontiers in Oncology.

Synergistic antitumor effect of tumor necrosis factor–related apoptosis‐inducing ligand combined with cisplatin in ovarian carcinoma cell lines in vitro and in vivo

P. Hou, P. Liu, H. Mao, 2005, International Journal of Gynecologic Cancer.

Synergistic antitumor effect of tumor necrosis factor–related apoptosis‐inducing ligand combined with cisplatin in ovarian carcinoma cell lines in vitro and in vivo

P. Hou, P. Liu, H. Mao, 2005, International Journal of Gynecologic Cancer.

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer

Xuan Wei, Peishu Liu, Yingxin Pang, 2019, OncoTargets and therapy.

The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer

J. Li, Jing Zhao, Xuan Wei, 2022, Journal of translational medicine.

Risk of parametrial invasion in women with early stage cervical cancer: a meta-analysis

Peishu Liu, Congcong Ma, Rui Li, 2018, Archives of Gynecology and Obstetrics.

CMAR_A_337873 9015..9024

Xuan Wei, Peishu Liu, Xueyao Huang, 2021 .

Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro.

Gang Xin, G. Xin, Chunxi Liu, 2007, Pharmacological research.

Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.

Xiaolei Zhang, Peishu Liu, Yingxin Pang, 2013, Oncology reports.

Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies

Xinrui Zhao, Peishu Liu, J. Xue, 2018, Archives of Gynecology and Obstetrics.

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit

Yingxin Pang, Yue Hou, Xuan Wei, 2023, Frontiers in Genetics.

Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.

Xiaolei Zhang, Juan Li, Peishu Liu, 2009, Oncology reports.

Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer

Yong-mei Yang, Qi Hao, Liang Shen, 2012, Regulatory Peptides.

Risk of endometrial polyps in women with endometriosis: a meta-analysis

J. Zhao, Xuan Wei, Qiaomei Zheng, 2015, Reproductive Biology and Endocrinology.

Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.

Yunxia Wang, Xietong Wang, Peishu Liu, 2017, Molecular medicine reports.

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo

Xuan Wei, Peishu Liu, X. Zong, 2017, OncoTargets and therapy.

Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo

Xiaolei Zhang, Peishu Liu, Yingxin Pang, 2020, OncoTargets and therapy.

GABPA Expression in Endometrial Carcinoma: A Prognostic Marker

Xuan Wei, Peishu Liu, Qianhan Lin, 2021, Disease markers.

Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.

Xiaolei Zhang, Liang Shen, Peishu Liu, 2013, International journal of molecular medicine.

ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo

Xuan Wei, Peishu Liu, Tianfeng Liu, 2019, Journal of Translational Medicine.

Can postoperative GnRH agonist treatment prevent endometriosis recurrence? A meta-analysis

J. Zhao, Xuan Wei, Qiaomei Zheng, 2016, Archives of Gynecology and Obstetrics.

Ectopic repression of receptor tyrosine kinase–like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial–mesenchymal transition

Peishu Liu, Y. Pang, Zhendan Zhao, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Xuan Wei, Peishu Liu, Qianhan Lin, 2021, Frontiers in Oncology.

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP

Liang Shen, Peishu Liu, Yingxin Pang, 2014, OncoTargets and therapy.

Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis

Xuan Wei, Peishu Liu, Xueyao Huang, 2021, Cancer management and research.

Conservative management of endometrial stromal sarcoma at stage III: A case report

Peihai Zhang, H. Mao, Ruiying Dong, 2014, Oncology letters.

Successful pregnancy following conservative management of low-grade endometrial stromal sarcoma: A case report

Ning Yang, Peishu Liu, Yingxin Pang, 2014, Oncology letters.

ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo

Xuan Wei, Peishu Liu, Tianfeng Liu, 2019, Journal of Translational Medicine.

Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients

Yue Zhou, Peishu Liu, Sijing Qiao, 2023, Journal of inflammation research.

MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer

Xinrui Zhao, Hui Xu, Peishu Liu, 2020, Journal of Ovarian Research.